Cargando…
Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis
BACKGROUND: Viral bronchiolitis is the leading cause of hospitalization in young infants. It is associated with the development of childhood asthma and contributes to morbidity and mortality in the elderly. Currently no therapies effectively attenuate inflammation during the acute viral infection, o...
Autores principales: | Beigelman, Avraham, Mikols, Cassandra L, Gunsten, Sean P, Cannon, Carolyn L, Brody, Steven L, Walter, Michael J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906448/ https://www.ncbi.nlm.nih.gov/pubmed/20591166 http://dx.doi.org/10.1186/1465-9921-11-90 |
Ejemplares similares
-
Azithromycin in acute bronchiolitis
por: Solé, Dirceu, et al.
Publicado: (2020) -
Long-term effect of azithromycin in bronchiolitis obliterans syndrome
por: Gan, C.Tji-Joong, et al.
Publicado: (2019) -
The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population
por: Srinivasan, Mythili, et al.
Publicado: (2021) -
Viral bronchiolitis
por: Florin, Todd A, et al.
Publicado: (2017) -
3439 Role of the Airway Microbiome in Viral Bronchiolitis Associated Respiratory Failure
por: Wasserman, Emily, et al.
Publicado: (2019)